Wintrust Investments LLC Trims Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wintrust Investments LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,298 shares of the medical equipment provider’s stock after selling 201 shares during the quarter. Intuitive Surgical makes up about 2.0% of Wintrust Investments LLC’s investment portfolio, making the stock its 11th largest holding. Wintrust Investments LLC’s holdings in Intuitive Surgical were worth $2,243,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $31,000. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth $36,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $497.30 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $177.13 billion, a PE ratio of 77.58, a PEG ratio of 5.85 and a beta of 1.43. The stock has a fifty day simple moving average of $569.42 and a two-hundred day simple moving average of $531.60.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,209 shares of company stock valued at $11,928,127. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Evercore ISI upped their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.